Deep Dive - MINT: opportunities in ‘frontier’ markets?
Published in Pharmaphorum’s Deep Dive magazine October 2017
According to British economist Jim O’Neill, MINT is the new BRIC. What is MINT? An acronym he coined for the ‘frontier’ markets of Mexico, Indonesia, Nigeria and Turkey. These are the countries he believes are poised for strong economic growth, like the emerging markets of BRIC (Brazil, Russia, India and China) before them. What are the prospects for pharma in MINT? Research Partnership’s Rachel Howard and Sue Rees investigate the pros and cons.
Webcast: Going for growth - Maximising your return on insights in Emerging Markets
Healthcare market research in emerging markets is still evolving, so finding the insights you require and then maximising the return on those insights can be challenging. Download this complimentary webcast in which Emerging Markets Directors Marc Yates and Rachel Howard will provide you with the critical success factors to ensure actionable primary research in emerging markets.